Savaysa: payments to doctors
Payments that named Savaysa as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.6M
- Providers
- 35
- Transactions
- 280
- Average per transaction
- $5,712
The per-transaction average — $5,712 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 35 providers the average total is $45,698, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Daiichi Sankyo Inc. | $1,406,463 | 87.9% |
| Daiichi Sankyo Company LTD | $161,840 | 10.1% |
| Daiichi Sankyo Europe GmbH | $31,110 | 1.9% |